Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: A sign of a pre-hypertensive state?

Human Reproduction

Volumn 11, Issue 1, 1996, Pages 23-28

  Holte, J ^a   Gennarelli, G ^a   Berne, C ^a   Bergh, T ^a   Lithell, H ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood pressure; Insulin; Insulin resistance; Polycystic ovary syndrome; Testosterone

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; FATTY ACID; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ABDOMEN; ADULT; AMBULATORY MONITORING; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY FAT; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LUTEINIZING HORMONE BLOOD LEVEL; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; OVARY; OVARY POLYCYSTIC DISEASE; PULSE RATE; RISK FACTOR; SKINFOLD THICKNESS; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; TRUNK;

EID: 0030047162     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019028     Document Type: Article

References (32)

1. Adams, J., Poison, D.W. and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J., 293, 355-359.
2. Antula, L., Koskinen, P., Jaatinen. T., Erkkola, R., Irjala, K. and Ruutiainen, K. (1993) Insulin hypersecretion together with high luteinizing hormone concentration augments androgen secretion in oral glucose tolerance test in women with polycystic ovarian disease. Hum. Reprod., 8, H79-1183.
3. Berne, C., Fagms, J., Pollare, T. and Hjemdahl, P. (1992) The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia, 35, 873-879.
4. Chen, Y.F. and Meng, Q.C. (1991) Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci., 48, 85-96.
5. Conway, G.S., Agrawal. R., Betteridge, D.J. and Jacobs, H.S. (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin. Endocrinol., 37, 119-125.
6. Dahlgren, E., Johansson, S., Lindstedt, G., Knutsson. F., Oden, A et al. (1992) Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fenil. Steril, 57, 505-513.
7. de Faire, U., Lindvall, K. and Nilsson, B. (1993) Noninvasive ambulatory 24 h blood pressures and basal blood pressures predict development of sustained hypertension from a borderline state. Am. J. Hypertens., 6, 149-155.
8. Dunaif, A., Segal, K.R., Futterweit, W. and Dobrjansky, A. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-1174.
9. Falcone, T., Little, A.B. and Moms, D. (1992) Impaired glucose effectiveness in patients with polycystic ovary syndrome. Hum. Reprod. 7, 922-925.
10. Ferrannini, E., Buzzigoli, G. and Bonadonna, R.C. (1987) Insulin resistance in essential hypertension. N. Engl. J. Med., 317, 350-357.
11. Ferrannim, E., Haffner, S M. and Stern, M.P. (1990) Essential hypertension: an insulin-resistant state. J. Cardiovasc. Pharmacol., 15 (Suppl. 5). S18-S25.
12. Ferriman, D. and Gallwey, J.D. (1961) Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab., 21, 1440-1447.
13. Graf, M.J., Richards, C.J., Brown, V., Meissner, L. and Dunaif, A. (1990) The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women. Clin. Endocrinol., 33, 119-131.
14. Holmäng, A., Svedberg. J., Jennische, E. and Bjorntorp, P. (1990) Effects of testosterone on muscle insulin sensitivity and morphology in female rats. Am J. Physiol., 259, E555-E560.
15. Holte, J., Bergh, T., Berne. C., Berglund, L. and Lithell, H. (1994a) Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J. Clin. Endocnnol. Metab., 78, 1052-1058.
16. Holte, J., Bergh, T., Berne, C. and Lithell, H. (1994b) Serum lipoprotein lipid profile in women with the polycystic ovary syndrome - relation to anthropometrie, endocrine and metabolic variables. Clin. Endocrinol., 41, 463-471.
17. Holte, J., Bergh, T., Berne, C., Wide, L. and Lithell, H. (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol Metab . 80, 2586-2593.
18. Insler, V., Shoham, Z., Barash. A., Koistinen, R., Seppälä, M., Hen, M., et al. (1993) Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings. Hum. Reprod., 8, 379-384.
19. Julius, S., Gudbrandsson, T., Jamerson, K. and Andersson, O. (1992) The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Pressure. 1, 9-19.
20. Lobo, R.A., Granger, L.R., Paul, W.L., Goebelsmann, U. and Mishell, D.J. (1983) Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am. J. Obstet. Gynecol, 145, 496-503.
21. Mårin, P., Darin, N., Amemiya, T., Andersson. B . Jern, S. and Björntorp, P. (1992) Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism, 41, 882-886.
22. Mattsson, L.A., Cullberg, G., Hamberger, L., Samsioe, G. and Silfverstolpe, G. (1984) Lipid metabolism in women with polycystic ovary syndrome: possible implications for an increased risk of coronary heart disease. Fertil. Steril., 42, 579-584.
23. Pasquali, R., Cantobelli, S. and Casimiri, F. (1993) The hypothalamicpituitary-adrenal axis in obese women with different patterns of body fat distribution. J. Clin. Endocrinol. Metab., 77, 341-346.
24. Pollare, T., Lithell, H. and Berne, C (1990) Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism, 39, 167-174.
25. Rebuffé-Scrive, M., Cullberg, G., Lundberg. P.A., Lindstedt, G. and Björntorp, P. (1989) Anthropometric variables and metabolism in polycystic ovarian disease. Horm. Metab. Res., 21, 391-397.
26. Rosner, W. (1972) A simplified method for the quantitative determination of testosterone-estradiol-binding globulin activity. J. Clin. Endocrinol. Meiab., 34, 983-988.
27. Skarfors. E.T., Lithell, H.O., Selinus, I and Åberg, H. (1989) Do antihypertensive drugs precipitate diabetes in predisposed men? Br. Med. J., 298, 1147-1152.
28. Spielberger, C. (1983) Manual for the State-Trait Anxiety Inventory (form Y). Consulting Psychologists Press Inc., Palo Alto. CA, USA.
29. Whitworth, J.A, (1994) Studies on the mechanisms of glucocorticoid hypertension in humans. Blood Pressure. 3, 24-32.
30. Wu, Z.V., Wu, X.K., and Zhang, Y.W. (1990) Relationship of menopausal status and sex hormones to serum lipids and blood pressure. Int. J. Epidemiol., 19, 297-302.
31. Zavaroni, I., Bonora, E. and Pagliara, M. (1989) Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N. Engl. J. Med., 326, 702-706.
32. Zimmermann, S., Phillips, R A., Dunaif, A., Finegood, D.T., Wilkenfeld, C. et al. (1992) Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance. J. Clin. Endocrinol Metab., 75, 508-513.